| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $551.1M | $572.5M | $627.6M |
| YoY Revenue Growth % | -3.7% | -8.8% | — |
| Gross Profit | $227.3M | $256.8M | — |
| Gross Margin % | 41.2% | 44.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$72.5M | -$85.7M | -$87.6M |
| Operating Margin % | -13.2% | -15.0% | -14.0% |
| Net Income (GAAP) | $0 | $0 | -$123.1M |
| EBITDA (Normalized) | -$54.8M | -$77.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $15.1M | $7.8M | -$61.6M |
| Capital Expenditures (CapEx) | $22.1M | $10.9M | — |
| Free Cash Flow (FCF) | -$7.0M | -$3.0M | -$61.6M |
| FCF Margin % | -1.3% | -0.5% | -9.8% |
| Return on Invested Capital (ROIC %) | -7.7% | -9.4% | — |
| Cash & Short-Term Equivalents | $94.5M | $70.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $842.9M | $793.0M | — |